ACE2 polymorphisms impact COVID-19 severity in obese patients.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
13 12 2022
13 12 2022
Historique:
received:
26
05
2022
accepted:
08
12
2022
entrez:
13
12
2022
pubmed:
14
12
2022
medline:
16
12
2022
Statut:
epublish
Résumé
A strong association between obesity and COVID-19 complications and a lack of prognostic factors that explain the unpredictable severity among these patients still exist despite the various vaccination programs. The expression of angiotensin converting enzyme 2 (ACE2), the main receptor for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is enhanced in obese individuals. The occurrence of frequent genetic single nucleotide polymorphisms (SNPs) in ACE2 is suggested to increase COVID-19 severity. Accordingly, we hypothesize that obesity-associated ACE2 polymorphisms increase the severity of COVID-19. In this study, we profiled eight frequently reported ACE2 SNPs in a cohort of lean and obese COVID-19 patients (n = 82). We highlight the significant association of rs2285666, rs2048683, rs879922, and rs4240157 with increased severity in obese COVID-19 patients as compared to lean counterparts. These co-morbid-associated SNPs tend to positively correlate, hence proposing possible functional cooperation to ACE2 regulation. In obese COVID-19 patients, rs2285666, rs879922, and rs4240157 are significantly associated with increased blood nitrogen urea and creatinine levels. In conclusion, we highlight the contribution of ACE2 SNPs in enhancing COVID-19 severity in obese individuals. The results from this study provide a basis for further investigations required to shed light on the underlying mechanisms of COVID-19 associated SNPs in COVID-19 obese patients.
Identifiants
pubmed: 36513710
doi: 10.1038/s41598-022-26072-7
pii: 10.1038/s41598-022-26072-7
pmc: PMC9748040
doi:
Substances chimiques
Angiotensin-Converting Enzyme 2
EC 3.4.17.23
ACE2 protein, human
EC 3.4.17.23
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
21491Informations de copyright
© 2022. Crown.
Références
Theranostics. 2021 Jul 13;11(17):8234-8253
pubmed: 34373739
Mayo Clin Proc. 2020 Jul;95(7):1445-1453
pubmed: 32622449
Nucleic Acids Res. 2003 Jul 1;31(13):3812-4
pubmed: 12824425
J Clin Endocrinol Metab. 2021 Nov 19;106(12):e5030-e5042
pubmed: 34297116
Clin Infect Dis. 2011 Feb 1;52(3):301-12
pubmed: 21208911
J Immunol. 2014 Sep 15;193(6):3080-9
pubmed: 25135833
Aging Cell. 2020 Jul;19(7):
pubmed: 32558150
FASEB J. 2020 May;34(5):6017-6026
pubmed: 32306452
Proc Natl Acad Sci U S A. 2020 Sep 1;117(35):21011-21013
pubmed: 32788355
Front Physiol. 2012 Sep 12;3:364
pubmed: 22988445
J Clin Lab Anal. 2017 Mar;31(2):
pubmed: 27500554
Mol Genet Genomic Med. 2021 Jun;9(6):e1672
pubmed: 33818000
Arch Virol. 2021 Aug;166(8):2089-2108
pubmed: 33934196
Brief Bioinform. 2013 Mar;14(2):178-92
pubmed: 22517427
Mol Nutr Food Res. 2011 Jan;55(1):136-49
pubmed: 21207518
Eur J Intern Med. 2021 Sep;91:3-9
pubmed: 33858724
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
PLoS One. 2022 Feb 4;17(2):e0263140
pubmed: 35120165
Eur J Clin Microbiol Infect Dis. 2016 Mar;35(3):325-31
pubmed: 26718941
Front Physiol. 2020 Sep 18;11:555039
pubmed: 33071815
Int J Obes (Lond). 2008 Sep;32(9):1431-7
pubmed: 18607383
Diabetes Obes Metab. 2021 Jan;23(1):258-262
pubmed: 32969132
Front Public Health. 2021 Oct 29;9:724494
pubmed: 34778167
Saudi J Biol Sci. 2021 Feb;28(2):1445-1450
pubmed: 33293887
J Pathol Clin Res. 2015 Mar 16;1(2):113-23
pubmed: 27499898
Virol J. 2022 Mar 19;19(1):48
pubmed: 35305693
PLoS One. 2020 Dec 28;15(12):e0243887
pubmed: 33370311
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
Gene. 2020 Dec 15;762:145102
pubmed: 32882331
Front Cell Infect Microbiol. 2018 Oct 08;8:343
pubmed: 30349811
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Int J Obes (Lond). 2017 Sep;41(9):1324-1330
pubmed: 28584297
Cell Metab. 2021 Mar 2;33(3):479-498
pubmed: 33529600
Gene Rep. 2021 Mar;22:100979
pubmed: 33294728
Front Genet. 2020 Sep 25;11:564741
pubmed: 33101387
Vaccine. 2021 Oct 15;39(43):6341-6345
pubmed: 34561138
Front Immunol. 2022 May 19;13:827603
pubmed: 35663953
Am J Hum Genet. 2020 Sep 3;107(3):381-402
pubmed: 32814065
medRxiv. 2021 Feb 27;:
pubmed: 33655273
Aging (Albany NY). 2020 Jun 5;12(11):10087-10098
pubmed: 32501810